Ascribe Bio
PrivateLast Round
Series A
Oct 14, 2025
Total Funding Raised
$14.5M
Company Overview
Ascribe Bio is an agricultural technology company that develops natural crop protection solutions derived from the soil microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ascribe Bio Comps
Public and private peers based on sector, stage, and business model.
Ascribe Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 14, 2025 | ||||
| Seed | Nov 11, 2021 |
Ascribe Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cultivation Capital | Series A |
| Ponderosa Ventures | Seed |
| Acre Venture Partners | Series A, Seed |
| Syngenta Group Ventures | Series A |
| Trailhead Capital | Series A, Seed |
| The Yield Lab | Series A, Seed |
| SilverBlue | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2025
$12M round completed.
Ascribe Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ascribe Bio's valuation, stock price, and market status.
